Cantor Fitzgerald Reiterates Overweight on Marinus Pharma, Maintains $28 Price Target
Cantor Fitzgerald analyst Charles Duncan reiterates Marinus Pharma (NASDAQ:MRNS) with a Overweight and maintains $28 price target.
RBC Capital Maintains Outperform on Marinus Pharma, Lowers Price Target to $22
RBC Capital analyst Brian Abrahams maintains Marinus Pharma (NASDAQ:MRNS) with a Outperform and lowers the price target from $23 to $22.
Noting Strong Progress On Marinus Pharma’s Lead Drug Ganaxolone, Analyst Initiates With 300% Upside
RBC Capital Markets initiated coverage on Marinus Pharmaceuticals Inc (NASDAQ:MRNS) with an Outperform rating, Speculative Risk, and a price target of…
RBC Capital Initiates Coverage On Marinus Pharma with Outperform Rating, Announces Price Target of $23
RBC Capital analyst Brian Abrahams initiates coverage on Marinus Pharma (NASDAQ:MRNS) with a Outperform rating and announces Price Target of $23.
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 325 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Thursday
Thursday's session saw 329 companies set new 52-week lows.
Baird Maintains Outperform on Marinus Pharma, Lowers Price Target to $24
Baird analyst Brian Skorney maintains Marinus Pharma (NASDAQ:MRNS) with a Outperform and lowers the price target from $32 to $24.
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday
Gainers
Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday.
Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast cancer cryoablation procedures.
12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers
NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares rose 49.1% to $3.22 during Tuesday's pre-market session. The company's market cap stands at $2.8 million.